KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Times Interest Earned (2018 - 2019)

Historic Times Interest Earned for Acadia Pharmaceuticals (ACAD) over the last 4 years, with Q2 2019 value amounting to -$4757.6.

  • Acadia Pharmaceuticals' Times Interest Earned fell 173386.61% to -$4757.6 in Q2 2019 from the same period last year, while for Mar 2020 it was -$20702.2, marking a year-over-year decrease of 1518328.54%. This contributed to the annual value of -$134.48 for FY2018, which is N/A changed from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Times Interest Earned stood at -$4757.6 for Q2 2019, which was down 173386.61% from -$382.68 recorded in Q1 2019.
  • Over the past 5 years, Acadia Pharmaceuticals' Times Interest Earned peaked at $529.72 during Q4 2018, and registered a low of -$4757.6 during Q2 2019.